CLL-derived products had generally increased transcript levels of LAG3, CD69, ID2, and SLAMF7, several chemokines and long non-coding RNAs (lncRNAs), as well as HLA class molecules and cytotoxicity markers (Figures 6A and 6C). This evidence concerns the gene CD69 and B-cell chronic lymphocytic leukemia.